GLP-1 agonists , or glucagon-like peptide-1 substances, are representing as a remarkable development in managing diabetes mellitus . These innovative therapies function to increasing insulin release and https://glp1048567.blog5.net/94210875/glp-1-a-promising-method-in-blood-sugar-treatment